With the gradual recovery of markets from the aftermath of the COVID-19 pandemic, the healthcare industry is likely to witness a positive impact during the forecast period.
With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
The recovery process involves various phases including:-
- Recognizing the existing business model
- Identifying potential disruptions
- Assessing Impact on Critical IT infrastructure and Software System
Download the Post-Pandemic Business Planning Structure
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
Get Access to On-demand, Syndicated Extensive Research Reports using Technavio's Subscription Platform
Technavio's SUBSCRIPTION platform
Emerging Opportunities with Key players
Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. offers ondansetron hydrochloride, which is a serotonin receptor antagonist which is used for the treatment of chemotherapy-induced nausea and vomiting.
Cipla Inc.
Cipla Inc. offers EMESET, which is a serotonin receptor antagonist which is used for the treatment of chemotherapy-induced nausea and vomiting.
Dr. Reddys Laboratories Ltd.
Dr. Reddys Laboratories Ltd. offers Palonosetron Hydrochloride Injection, which is a single-dose vial injection that is used for chemotherapy-induced nausea and vomiting.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown: https://www.technavio.com/report/chemotherapy-induced-nausea-and-vomiting-drugs-market-industry-analysis
Chemotherapy-induced Nausea And Vomiting Drugs Market 2021-2025: Segmentation
The chemotherapy-induced nausea and vomiting drugs market is segmented as below:
- Geography
o North America
o Europe
o Asia
o ROW
- Therapy
o Serotonin Receptor Antagonists
o NK1 Receptor Antagonists
o Others
Chemotherapy-induced nausea and vomiting drugs market is driven by the growing cancer population. In addition, the approval of new drugs fuels the market growth is expected to trigger the chemotherapy-induced nausea and vomiting drugs market toward witnessing a CAGR of 6.08% during the forecast period.
Get Actionable Insights on each Contributing Segments. Download Free Sample Report:
https://www.technavio.com/talk-to-us?report=IRTNTR44291
Corresponding Reports:
Global Drug Discovery Outsourcing Market- The drug discovery outsourcing market is segmented by product (small molecules and biologics) and geography (North America, Europe, Asia, and ROW).
Download FREE Sample Report
Global Cell Culture Media and Reagents Market- The cell culture media and reagents market is segmented by end-user (pharmaceutical and biotechnology industry, academic institutions and research laboratories, and others) and geography (North America, Asia, Europe, and ROW).
Download FREE Sample Report
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Report link: https://www.technavio.com/report/chemotherapy-induced-nausea-and-vomiting-drugs-market-industry-analysis
Newsroom: https://newsroom.technavio.com/news/chemotherapy-induced-nausea-and-vomiting-drugsmarket
SOURCE Technavio
Share this article